SCHEMBL5558

SCHEMBL5558

C[C@]1(O)CC[C@]2(CCN(c3ccc(C4CC4)cc3)C2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.46
ITGB3 P05106 5/20 0.38
ITGA2B P08514 5/20 0.38
CYP3A4 P08684 6/20 0.37
CYP2C19 P33261 4/20 0.37
HIF1A Q16665 3/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2C9 P11712 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
USP2 O75604 2/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
MAPK1 P28482 2/20 0.35
SLC18A3 Q16572 1/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924 0.83 ITGB3 (0.38) ESR2ITGB3ITGA2BCYP3A4CYP2C19
SCHEMBL5381 0.82 CYP3A4 (0.39) ITGB3ITGA2BCYP3A4CYP2C19HIF1A
SCHEMBL5843 0.80 ITGB3 (0.37) ITGB3ITGA2BCYP3A4CYP2C19HIF1A
SCHEMBL1957562 0.79 CYP2D6 (0.54) CYP3A4CYP2C19HIF1AALDH1A1CYP1A2
SCHEMBL5474 0.78 ITGB3 (0.36) ITGB3ITGA2BCYP3A4CYP2C19HIF1A
SCHEMBL5019 0.74 SLC6A4 (0.49)
SCHEMBL1959401 0.74 KMT2A (0.52) MEN1KMT2ASLC18A3
SCHEMBL1959932 0.72 KCNH2 (0.38) CYP3A4CYP2C19HIF1AALDH1A1CYP1A2
SCHEMBL2635048 0.71 HRH3 (0.64) HRH3
SCHEMBL1962030 0.71 KCNH2 (0.60) CYP3A4CYP2C19CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP claimed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO claimed